New nasal spray vaccine tested to protect babies from RSV
NCT ID NCT06705140
Summary
This study tested a new nasal spray vaccine designed to protect infants and toddlers from Respiratory Syncytial Virus (RSV), a common cause of severe lung infections in young children. It involved about 950 healthy children aged 6 months to under 2 years old. The main goals were to see if a lower dose of the vaccine worked as well as a standard dose and to carefully check the safety of different doses.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RSV IMMUNISATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational Site Number : 2140002
Santo Domingo, 10201, Dominican Republic
-
Investigational Site Number : 3400001
Tegucigalpa, 11101, Honduras
-
Investigational Site Number : 3400002
San Pedro Sula, Honduras
-
Investigational Site Number : 3400003
Tegucigalpa, 11101, Honduras
Conditions
Explore the condition pages connected to this study.